Luina Bio Revenue and Competitors

Brisbane, Australia

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Luina Bio's estimated annual revenue is currently $13.6M per year.(i)
  • Luina Bio's estimated revenue per employee is $155,000

Employee Data

  • Luina Bio has 88 Employees.(i)
  • Luina Bio grew their employee count by -14% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$52.4M33828%N/AN/A
#2
$13.8M899%N/AN/A
#3
$17.1M11033%N/AN/A
#4
$17.2M11150%N/AN/A
#5
$42.2M27211%N/AN/A
#6
$8.7M5614%N/AN/A
#7
$13.6M88-14%N/AN/A
#8
$12.9M83-6%N/AN/A
#9
$16.9M1098%N/AN/A
#10
$21.2M137-4%$33.8MN/A
Add Company

Luina Bio Pty Ltd is one of Australia's most experienced biopharmaceutical contract manufacturing organisations. Luina Bio is conveniently located in Brisbane, Queensland. We offer an inclusive set of services including process development and GMP manufacture of recombinant proteins, vaccines and live bio-therapeutics for human and veterinary use. We can produce material for pre-clinical studies and clinical trial GMP batches for Phase 1, 2 and 3 clinical studies. We have more than 20 years of contract manufacturing experience with a dedicated team of highly educated and trained personnel. We have worked with Australian, European, American and Asian clients supporting their development needs. We maintain a TGA/APVMA/OGTR inspected and approved facility that offers optimum flexibility to keep you development rate fast and your costs low while ensuring quality is never compromised. Luina Bio was previously known under the name PharmaSynth.

keywords:N/A

N/A

Total Funding

88

Number of Employees

$13.6M

Revenue (est)

-14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Luina Bio News

2022-04-17 - Liveome draws ?7billion Series A funding < Pharma < ?? ...

... clinical drugs with global contract development and manufacturing organization (CDMO) companies, such as Luina Bio and Quay Pharma.

2022-04-17 - Plasmid DNA Manufacturing Market Size and Future Business ...

... Delphi Genetics, Biomiga, GeneImmune Biotechnology Corp., Lonza, Greenpak Biotech Ltd, Luina Bio Pty Ltd, Ajinomoto Bio-Pharma Services,...

2022-03-30 - The live biotherapeutic products and microbiome ...

... Luina Bio); Gaurav Kaushik (Managing Director and Chief Executive Officer, Meteoric Biopharmaceuticals); Veronika Oudova (Co-founder and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.9M89N/AN/A
#2
$21.8M8924%N/A
#3
$20.4M9025%N/A
#4
$24.3M9041%N/A
#5
$10.8M901%N/A